Guanfacine
NDC Package 63304-926-01

11-digit billing NDC: 63304092601 · Billing unit: EA · 100 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Guanfacine is extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)]. Marketed by Sun Pharmaceutical Industries, Inc, this product is identified by NDC 63304-926 and is authorized under FDA application ANDA205689.

Identification & Billing

NDC Package Code
63304-926-01
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
11-Digit Billing Format
63304092601
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Guanfacine
Dosage Form
-
Usage Information
Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical Studies (14)].

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries, Inc
FDA Application #
ANDA205689
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-17-2018
End Marketing Date
02-28-2025
Listing Expiration
02-28-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63304-926). Click a package code to view its specific billing and regulatory data.

500 TABLET, EXTENDED RELEASE in 1 BOTTLE
30 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63304-926-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Guanfacine, labeled by Sun Pharmaceutical Industries, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc on August 17, 2018. The current certification is valid through February 28, 2025.

How is this Sun Pharmaceutical Industries, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63304092601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63304-926-01
11-Digit CMS (5-4-2)
63304-0926-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.